Medicine and Dentistry
Opiate
60%
Morphine
50%
Chemotherapeutic Agent
43%
Drug
43%
Therapeutic Procedure
32%
Electroencephalogram
28%
Central Nervous System
25%
Brain
25%
Anorectal Manometry
24%
Drug Absorption
24%
Patient
24%
Inpatient
24%
Pain
24%
Female
19%
Gastroesophageal Reflux
18%
Esophagus
16%
Food Intake
16%
Diseases
16%
Parity
14%
Gender Difference
14%
Assessment
14%
17 Methylnaltrexone
13%
Measurement
13%
Analysis
12%
Esophageal Disorder
12%
Antagonist
12%
Analgesia
11%
Water
11%
Withdrawal Reflex
11%
Malignant Neoplasm
10%
Analgesic Activity
10%
Anal Canal
9%
Coughing
9%
Patient Population
9%
Receptor
9%
Stimulation
9%
κ-Opioid Receptor
9%
Male
8%
Pharmacokinetics
8%
Functional Magnetic Resonance Imaging
8%
Drug Metabolism
8%
Exocrine Pancreatic Insufficiency
8%
Drug Interaction
8%
Gastrointestinal Motility
8%
Malabsorption
8%
Bacterial Overgrowth
8%
Secretion (Process)
8%
Lifestyle
8%
Pathophysiology
8%
Experience
8%
Pharmacology, Toxicology and Pharmaceutical Science
Morphine
75%
Opiate
53%
Chronic Pancreatitis
49%
Drug
43%
Pain
27%
Normal Human
24%
Gastroesophageal Reflux
18%
Ethanol
16%
Diseases
16%
Prolactin
16%
Pharmacokinetics
15%
Methylnaltrexone
13%
Malignant Neoplasm
10%
Coughing
9%
Receptor
9%
Opiate Receptor
9%
Analgesic Agent
8%
Drug Interaction
8%
Exocrine Pancreatic Insufficiency
8%
Malabsorption
8%
Pathophysiology
8%
Water
8%
Dissolution
8%
Experimental Pain
7%
Linaclotide
6%
Baclofen
6%
Esophagus Pain
6%
Alginic Acid
6%
Ketamine
6%
Nursing and Health Professions
Morphine
100%
Procedures
34%
Opiate
32%
Electroencephalogram
28%
Placebo
24%
Gender
19%
Pressure
17%
Analgesia
16%
Prolactin
16%
Analysis
15%
Male
14%
Measurement
13%
Dose
12%
Electroencephalography
10%
Color
9%
Patient
9%
Coughing
9%
Stimulation
9%
Opiate Receptor
9%
Analgesic Agent
8%
Evoked Response
8%
Functional Magnetic Resonance Imaging
8%
Time
8%
Experimental Pain
7%
Parameters
6%
Hypertensive Factor
6%
Marker
5%
Experimental Muscle Pain
5%
Standard
5%
